Aegerion Pharmaceuticals, Inc. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from SC 13D/A 10 pages Voting Agreement

from SC 13D/A 4 pages Amendment to Agreement

from SC 13D/A 9 pages Confidentiality Agreement

from SC 13D/A 25 pages Nomination and Standstill Agreement

from SC 13D 1 page Joint Filing Agreement

from 8-K 50 pages $300,000,000 Aegerion Pharmaceuticals, Inc. 2.0% Convertible Senior Notes Due 2019 Purchase Agreement

from 425 50 pages $300,000,000 Aegerion Pharmaceuticals, Inc. 2.0% Convertible Senior Notes Due 2019 Purchase Agreement

from 8-K 48 pages 2,704,739 Shares Aegerion Pharmaceuticals, Inc. Common Stock Underwriting Agreement

from 8-K 43 pages 3,400,000 Shares Aegerion Pharmaceuticals, Inc. Common Stock Underwriting Agreement

from S-1/A 54 pages [ ] Shares Aegerion Pharmaceuticals, Inc. Common Stock Underwriting Agreement

from S-1/A 39 pages Aegerion Pharmaceuticals, Inc. (A Delaware Corporation) [•] Shares of Common Stock Underwriting Agreement

from S-1/A 36 pages 5,000,000 Aegerion Pharmaceuticals, Inc. Common Stock Underwriting Agreement